Automating stochastic antibody–drug conjugation: a self-driving lab approach for enhanced therapeutic development
Open Access
- 24 February 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Digital Discovery
- Vol. 4 (4) , 979-986
Abstract
We introduce a Self-Driving Lab (SDL) for automated stochastic antibody-drug conjugation (ADC) and characterization. The robotic platform performs conjugations and determines drug to antibody ratios from chromatography data, enabling the production of target ADCs iteratively in a closed loop.Keywords
Funding Information
- Canada Foundation for Innovation (CFI-35883, CFI-44843)
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2021-03168)
- Canada First Research Excellence Fund (CFREF2022-00042)
- University of British Columbia
This publication has 26 references indexed in Scilit:
- Automated high-throughput buffer exchange platform enhances rapid flow analysis of antibody drug conjugates by high resolution mass spectrometryJournal of Chromatography B, 2024
- Online coupling of analytical hydrophobic interaction chromatography with native mass spectrometry for the characterization of monoclonal antibodies and related productsJournal of Pharmaceutical and Biomedical Analysis, 2020
- Antibody–drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successesJournal of Cellular Physiology, 2018
- Multi-step high-throughput conjugation platform for the development of antibody-drug conjugatesJournal of Biotechnology, 2018
- Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. II- Identification of sub-units for the characterization of even and odd load drug speciesJournal of Chromatography B, 2016
- Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. I − Optimization of separation conditionsJournal of Chromatography B, 2016
- Hydrophobic interaction chromatography for the characterization of monoclonal antibodies and related productsJournal of Pharmaceutical and Biomedical Analysis, 2016
- Drug-to-Antibody Ratio (DAR) and Drug Load Distribution by Hydrophobic Interaction Chromatography and Reversed Phase High-Performance Liquid Chromatography2013
- Drug-to-Antibody Ratio (DAR) by UV/Vis Spectroscopy2013
- Antibody–drug conjugates: targeted drug delivery for cancerCurrent Opinion in Chemical Biology, 2010